Xiaodong Wang, Director at BeOne Medicines Ltd. (ONC), sold 83,420 shares at $261.20 ($21.9M) on 2025-06-10, disclosed to the SEC on 2025-06-12.
Scheduled sale ($21.9M) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $261.20 | 2,901 | $758K | 3.5% |
| 2 | $261.20 | 2,901 | $758K | 3.5% |
| 3 | $262.20 | 15,878 | $4.2M | 19.0% |
| 4 | $262.20 | 15,878 | $4.2M | 19.0% |
| 5 | $263.17 | 16,094 | $4.2M | 19.3% |
| 6 | $263.17 | 16,094 |
| $4.2M |
| 19.3% |
| 7 | $264.08 | 6,787 | $1.8M | 8.2% |
| 8 | $264.08 | 6,787 | $1.8M | 8.2% |
| 9 | $264.85 | 100 | $26K | 0.1% |
| Total | $262.81 avg | 83,420 | $21.9M | 100% |
| Filing → |
| ONC | SELL | 2025-06-25 | $668K | — | Filing → |
| BGNE | SELL | 2025-05-15 | $18.6M | — | Filing → |
| BGNE | SELL | 2025-04-16 | $20.3M | — | Filing → |